Skip to main content

Analysts Offer Insights on Consumer Goods Companies: Constellation Brands (STZ), Costco (COST) and Clene (CLNN)

Tipranks - Tipranks - Tue Jan 13, 8:32PM CST

There’s a lot to be optimistic about in the Consumer Goods sector as 3 analysts just weighed in on Constellation Brands (STZ – Research Report), Costco (COST – Research Report) and Clene (CLNN – Research Report) with bullish sentiments.

Claim 70% Off TipRanks Premium

Constellation Brands (STZ)

In a report issued on January 9, Nik Modi from RBC Capital maintained a Buy rating on Constellation Brands, with a price target of $185.00. The company’s shares closed last Monday at $151.82.

According to TipRanks.com, Modi has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -4.8% and a 42.0% success rate. Modi covers the Consumer Goods sector, focusing on stocks such as The Estée Lauder Companies, Spectrum Brands Holdings, and Mondelez International. ;'>

Currently, the analyst consensus on Constellation Brands is a Moderate Buy with an average price target of $163.07, representing a 10.7% upside. In a report issued on January 8, TipRanks – PerPlexity also reiterated a Buy rating on the stock with a $162.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Costco (COST)

In a report released yesterday, Joe Feldman from Telsey Advisory maintained a Buy rating on Costco, with a price target of $1100.00. The company’s shares closed last Monday at $943.08.

According to TipRanks.com, Feldman is a 5-star analyst with an average return of 9.2% and a 54.2% success rate. Feldman covers the NA sector, focusing on stocks such as Floor & Decor Holdings, Dick’s Sporting Goods, and CAVA Group, Inc. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Costco with a $1052.38 average price target, implying a 14.3% upside from current levels. In a report released yesterday, DBS also maintained a Buy rating on the stock with a $1195.00 price target.

Clene (CLNN)

H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Clene yesterday and set a price target of $31.00. The company’s shares closed last Monday at $5.18.

According to TipRanks.com, Pantginis is a 5-star analyst with an average return of 13.6% and a 48.1% success rate. Pantginis covers the Healthcare sector, focusing on stocks such as Adlai Nortye Ltd. Sponsored ADR, NewAmsterdam Pharma Company, and Actinium Pharmaceuticals. ;'>

Currently, the analyst consensus on Clene is a Strong Buy with an average price target of $30.40.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).